Arax Advisory Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$455K Sell
1,023
-5
-0.5% -$2.23K 0.02% 410
2025
Q1
$498K Sell
1,028
-823
-44% -$399K 0.03% 317
2024
Q4
$745K Buy
1,851
+1,495
+420% +$602K 0.05% 217
2024
Q3
$166K Buy
356
+8
+2% +$3.72K 0.01% 384
2024
Q2
$163K Buy
348
+292
+521% +$137K 0.02% 368
2024
Q1
$23.4K Hold
56
﹤0.01% 643
2023
Q4
$22.8K Hold
56
﹤0.01% 627
2023
Q3
$19.5K Hold
56
﹤0.01% 587
2023
Q2
$19.7K Buy
56
+5
+10% +$1.76K ﹤0.01% 588
2023
Q1
$16.1K Buy
51
+13
+34% +$4.1K ﹤0.01% 618
2022
Q4
$11K Buy
38
+3
+9% +$866 ﹤0.01% 641
2022
Q3
$10K Sell
35
-10
-22% -$2.86K ﹤0.01% 669
2022
Q2
$13K Buy
45
+23
+105% +$6.64K ﹤0.01% 620
2022
Q1
$6K Sell
22
-28
-56% -$7.64K ﹤0.01% 755
2021
Q4
$11K Sell
50
-15
-23% -$3.3K ﹤0.01% 642
2021
Q3
$12K Buy
65
+5
+8% +$923 ﹤0.01% 623
2021
Q2
$12K Buy
+60
New +$12K ﹤0.01% 638
2020
Q4
$15K Buy
64
+4
+7% +$938 ﹤0.01% 528
2020
Q3
$16K Hold
60
﹤0.01% 498
2020
Q2
$17K Hold
60
﹤0.01% 492
2020
Q1
$14K Hold
60
﹤0.01% 498
2019
Q4
$13K Buy
60
+22
+58% +$4.77K ﹤0.01% 447
2019
Q3
$6K Hold
38
﹤0.01% 509
2019
Q2
$7K Buy
+38
New +$7K ﹤0.01% 497
2018
Q4
$6K Hold
38
﹤0.01% 481
2018
Q3
$7K Sell
38
-22
-37% -$4.05K ﹤0.01% 505
2018
Q2
$10K Sell
60
-5
-8% -$833 ﹤0.01% 346
2018
Q1
$10K Buy
65
+27
+71% +$4.15K 0.01% 328
2017
Q4
$5K Sell
38
-5
-12% -$658 ﹤0.01% 382
2017
Q3
$6K Buy
43
+5
+13% +$698 ﹤0.01% 363
2017
Q2
$5K Hold
38
﹤0.01% 390
2017
Q1
$4K Hold
38
﹤0.01% 382
2016
Q4
$3K Buy
+38
New +$3K ﹤0.01% 442